EyePoint Pharmaceuticals: A Puncher's Chance For Drug Success (NASDAQ:EYPT) : vimarsana.com

EyePoint Pharmaceuticals is a $200m market cap biotech focused on eye disease. Read more to see a full investment analysis of EYPT stock.

Related Keywords

Belgium , Massachusetts , United States , New York , Watertown , Belgian , Americans , Pharma Regeneron , Astellas Pharma , Iveric Bio , Pharma Oxurion , Jay Duker , Alimera Sciences , Kodiak Sciences , Genentech , Eyepoint Pharmaceuticals , Development To , Point Pharmaceuticals , Vorolanib Moa , Chief Operating Officer Dr Jay Duker , Step Back , Considering Some , Adverum Biotechnologies , Ocular Therapeutix , Clearside Biomedical , Belgian Pharma Oxurion , Unity Biotechnology , Impressed With , Geographic Atrophy Therapy ,